Gateway Investment Advisers’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Gateway Investment Advisers's DGX Position: Q2 2026 in Review
Gateway Investment Advisers reduced its Quest Diagnostics (DGX) stake by 28% in Q2 2026, selling an estimated $75.2K and leaving 1,003 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #761.
Gateway Investment Advisers first reported a position in DGX in Q2 2013 and has held it in 29 quarters since. The position peaked at $17.8M in Q2 2016. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Gateway Investment Advisers held 1,003 shares of Quest Diagnostics worth $213K as of Q2 2026.
- Gateway Investment Advisers sold 383 Quest Diagnostics shares in Q2 2026, an estimated $75.2K.
- Quest Diagnostics made up ﹤0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #761 holding.
- Gateway Investment Advisers first reported a position in Quest Diagnostics in Q2 2013 and has held it in 29 quarters since.
- Gateway Investment Advisers's Quest Diagnostics position peaked at $17.8M in Q2 2016.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.